Skip to main content
James Tsai, MD, Ophthalmology, New York, NY

JamesCTsaiMDMBA FACS

Ophthalmology New York, NY

Glaucoma Related

President, New York Eye and Ear Infirmary of Mount Sinai; Delafield-Rodgers Professor of Ophthalmology and System Chair, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai; Director, Barry Family Center for Ophthalmic Artificial Intelligence and Human Health (BFCOAIHH), Icahn School of Medicine at Mount Sinai; Mount Sinai Health System

Dr. Tsai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tsai's full profile

Already have an account?

  • Office

    310 East 14th Street
    Administration Suite
    New York, NY 10003
    Phone+1 212-979-4301
    Fax+1 212-979-4627

Summary

  • Dr. James Tsai is the Delafield-Rodgers Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY, specializing in complex glaucoma-related disorders. He completed his medical education at Stanford University School of Medicine and received his residency training in ophthalmology at the University of Southern California (USC) and Los Angeles General Medical Center. He undertook glaucoma fellowships at the University of Miami/Bascom Palmer Eye Institute and Moorfields Eye Hospital/Institute of Ophthalmology (London, UK). Dr. Tsai holds prominent leadership roles, including President of The New York Eye and Ear Infirmary of Mount Sinai and System Chair of Ophthalmology and Founding Director of the Barry Family Center for Ophthalmic Artificial Intelligence and Human Health at Icahn Mount Sinai. Dr. Tsai has published extensively on glaucoma and related ophthalmic topics. He has received numerous accolades, including The Jacobi Medallion and the Dr. Sidney Grossman Distinguished Humanitarian Award from Icahn Mount Sinai, the Notable Health Care Leaders Award from Crain's New York Business, the Physician Scientist Award from Fight for Sight, and the Lifetime Achievement Honor Award from the American Academy of Ophthalmology.

Education & Training

  • University of Miami Hospital and Clinics
    University of Miami Hospital and ClinicsFellowship, Glaucoma, 1993 - 1994
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1990 - 1993
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterInternship, Internal Medicine, 1989 - 1990
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1989

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1993 - 2027
  • CA State Medical License
    CA State Medical License 1990 - 2026
  • CT State Medical License
    CT State Medical License 2006 - 2025
  • NY State Medical License
    NY State Medical License 2001 - 2025
  • TN State Medical License
    TN State Medical License 1995 - 2007
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • The Jacobi Medallion Icahn School of Medicine at Mount Sinai, 2025
  • Dr. Sidney Grossman Distinguished Humanitarian Award Icahn School of Medicine at Mount Sinai, 2023
  • Notable Health Care Leaders Award Crain's New York Business, 2022
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • 9th Annual M. Bruce Shields Lecture - 19th Annual Yale Glaucoma Symposium 
    Yale University CME - 9/25/2015

Press Mentions

  • Schlemm Canal Microstenting
    Schlemm Canal MicrostentingNovember 27th, 2024
  • Mount Sinai Receives $5 Million Gift for the Center for Ophthalmic Artificial Intelligence and Human Health
    Mount Sinai Receives $5 Million Gift for the Center for Ophthalmic Artificial Intelligence and Human HealthOctober 16th, 2024
  • Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
    Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. AnnuallyDecember 29th, 2020
  • Join now to see all

Grant Support

  • “Unrestricted Departmental Grant to Icahn School of Medicine at Mount Sinai”Reseach to Prevent Blindness, Inc.2014–2015
  • “Unrestricted Departmental Grant to Icahn School of Medicine at Mount Sinai”Reseach to Prevent Blindness, Inc2013–2014
  • A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Primary Open-Angle GlaucomaNational Institutes of Health2011–2012
  • Early Diagnosis of Glaucomatous Optic Neuropathy by VEP Testing for Rapid Objective Detection of Impairment of Specific Visual SubsystemNational Institutes of Health2004–2005

Committees

  • Member, Special Emphasis Panel ZEY1-VSN (01),, National Eye Institute, National Institutes of Health 2015 - 2015
  • Ministry of Health, Singapore, Member, National Medical Research Council (NMRC) International Expert Panel 2014 - 2016
  • Member, Special Emphasis Panel ZEY1-VSN (01), National Eye Institute, National Institutes of Health 2014 - 2014
  • Member, AUPO Task Force on Resident Education, Association of University Professors of Ophthalmology (AUPO) 2013 - 2014

Professional Memberships